Established in 2016 and sponsored by Zcube, Zambon Research Venture, Open Accelerator has experienced significant growth over the years. In 2024, we are launching an entirely new program aimed at accelerating companies that are pioneering breakthrough innovations in women's health. The redesigned program will accelerate businesses developing new products by leveraging Zambon Group’s expertise.
We are actively seeking innovators whose solutions are reshaping the future of healthcare through the adoption of cutting-edge technologies, such as novel therapeutic approaches, medical devices, biomarkers, advanced analytics, and more. Our goal is to identify projects and startups that are revolutionizing the patient experience across the entire healthcare journey, covering aspects of healthy living, awareness and engagement, prevention, diagnosis, therapy, disease management, and follow-up care.
We are looking to establish meaningful collaborations with ambitious entrepreneurs dedicated to finding solutions to address the challenges women's health patients are currently facing.
We go beyond money: as part of the program, startups and projects will have access to the competences of our pharmaceutical group (Sales & Marketing, Clinical and Medical affairs, Regulatory, Reimbursement, etc.) and our high-level mentor network which melds science, business and investments. The Zambon Group could engage with selected startups and projects to discuss strategic collaborations and offer geographic exposure in the EU, US, Asia, and LatAm.
By participating in the OA program, the most promising entrepreneurs will have:
-
Direct access to capital (Up to €100K SAFE investment) and competences (Sales & Marketing, Clinical and Medical Affairs, Regulatory, Reimbursement, and much more).
-
The potential for future strategic collaborations with a company offering a global presence.
-
Exposure to a wide network of investors, corporates, advisors, and mentors!